Têxtil Renauxview Income Statement

Financials in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	115.88	117.68	132.71	212.42	162.08
Revenue Growth (YoY)	-1.53%	-11.32%	-37.52%	31.06%	94.03%
Cost of Revenue	91.32	95.46	113.7	147.46	106.2
Gross Profit	24.56	22.22	19.01	64.96	55.88
Selling, General & Admin	31.52	26.92	29.69	33.56	26
Other Operating Expenses	2.6	-0.19	-0.09	-0.62	-1.05
Operating Expenses	34.11	26.73	29.6	32.95	24.96
Operating Income	-9.55	-4.51	-10.59	32.02	30.93
Interest Expense	-24.95	-22.92	-31.58	-32.3	-54.8
Interest & Investment Income	0.11	0.04	0.87	1.42	0.12
Currency Exchange Gain (Loss)	0.96	-1.52	-	-	0.03
Other Non Operating Income (Expenses)	-12.75	-12.96	-	-	-0.67
EBT Excluding Unusual Items	-46.18	-41.86	-41.29	1.13	-24.4
Gain (Loss) on Sale of Assets	0.02	0.71	0.02	0.05	0.01
Legal Settlements	-10.91	-8.22	-	-	2.39
Other Unusual Items	0.13	9.9	58.06	-0.01	0.26
Pretax Income	-56.95	-39.46	16.79	1.17	-21.75
Income Tax Expense	0.15	-0.02	0.05	0.05	0.05
Net Income	-57.09	-39.45	16.75	1.12	-21.79
Net Income to Common	-57.09	-39.45	16.75	1.12	-21.79
Net Income Growth	-	-	1391.10%	-	-
Shares Outstanding (Basic)	4	4	4	4	4
Shares Outstanding (Diluted)	4	4	4	4	4
EPS (Basic)	-13.41	-9.26	3.93	0.26	-5.12
EPS (Diluted)	-13.41	-9.26	3.93	0.26	-5.12
EPS Growth	-	-	1391.10%	-	-
Gross Margin	21.19%	18.88%	14.33%	30.58%	34.48%
Operating Margin	-8.24%	-3.83%	-7.98%	15.07%	19.08%
Profit Margin	-49.27%	-33.52%	12.62%	0.53%	-13.44%
EBITDA	-5.37	0.17	-8	36.97	35.86
EBITDA Margin	-4.63%	0.15%	-6.03%	17.41%	22.13%
D&A For EBITDA	4.19	4.68	2.59	4.96	4.93
EBIT	-9.55	-4.51	-10.59	32.02	30.93
EBIT Margin	-8.24%	-3.83%	-7.98%	15.07%	19.08%
Effective Tax Rate	-	-	0.27%	3.85%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.